Funding event
The round itself, as filedInferred stagePre-seed
Sold of offered$1.1M of $1.4M
Filed2026-10-23
Days since filing21
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2022-06-20
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Audrey ChenExecutive Officer · Director
- Alan DavidnerDirector
- Phillip MerrittDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flagged$1.1M of $1.4M sold52.8 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-11-034
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
- Mechanical Engineering InternNOV 3Cambridge, MA · open 10 days
- Signal Processing & Algorithms Engineering InternNOV 3Cambridge, MA · open 10 days
- Embedded Systems & Controls Engineering InternNOV 3Cambridge, MA · open 10 days
- Technical Strategy & Commercialization InternNOV 3Cambridge, MA · open 10 days
Also raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.